Beta Drugs Limited IPO
Beta Drugs Limited is an NSE SME IPO is priced at ₹85 per share with an issue size of 22,96,000 Equity Shares of Rs 10 aggregating up to Rs 19.52 Cr . The IPO opens on Sep 29, 2017 and closes on Oct 4, 2017, with a lot size of 1600 shares and a minimum investment of ₹1,36,000.
Beta Drugs Limited IPO
- IPO Dates
- Sep 29, 2017 – Oct 4, 2017
- Price band
- ₹85 per equity share
- Minimum Investment
- ₹1,36,000
- Issue size
- 22,96,000 Equity Shares of Rs 10 aggregating up to Rs 19.52 Cr
- Lot size
- 1600
- Allotment Date
- Oct 9, 2017
- Listing
- Oct 12, 2017
- Listing At
- NSE SME
IPO timeline
-
Sep 29, 2017
Open Date
Completed
-
Oct 4, 2017
Close Date
Completed
-
Oct 9, 2017
Allotment Date
Completed
-
Oct 12, 2017
Listing Date
Completed
Beta Drugs Limited IPO Essentials
Beta Drugs Limited IPO Details
Beta Drugs Limited IPO is priced at ₹85 per share with a total issue size of 22,96,000 Equity Shares of Rs 10 aggregating up to Rs 19.52 Cr . The IPO has a lot size of 1600 shares and will be listed on NSE SME.
- Issue price
- Rs 85 Per Equity Share
- Lot size
- 1600 shares
- Face value
- Rs 10 Per Equity Share
- Issue size
- 22,96,000 Equity Shares of Rs 10 aggregating up to Rs 19.52 Cr
- Listing at
- NSE SME
- List price
- Listing date
- Registrar
- Link Intime India Private Ltd
- Lead manager
-
PANTOMATH CAPITAL ADVISORS PRIVATE LIMITED
Beta Drugs Limited IPO Details
- Retail Portion N/A
Beta Drugs Limited IPO Analytics
Beta Drugs Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Beta Drugs Limited IPO Subscription Status
Beta Drugs Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 10,83,200 | 10,83,200 | 21,66,400 |
|
Day 1
29-09-17
|
0.12 x | 0.05 x | 0.08 x |
|
Day 2
03-10-17
|
0.79 x | 0.62 x | 0.70 x |
|
Day 3
04-10-17
|
30.05 x | 7.99 x | 19.02 x |
|
Day 4
05-10-17
|
Beta Drugs Limited Valuations
Earnings
- EPS (Post IPO)
- Rs 5.99
- P/E Ratio
- 14.19
Returns
- RoNW
- 70.18%
Beta Drugs Limited Company & Offer Insights
Beta Drugs Limited IPO Issue Objectives
- •
- Purchase of new plant and machinery and up-gradation of our existing plant and machinery.
- •
- Civil Construction work at existing manufacturing unit.
- •
- To obtain registration of European Union GMP & Pharmaceutical Inspection Co-operation Scheme certificate.
- •
- Working Capital requirements.
- •
- General Corporate Purpose.
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Beta Drugs Limited IPO is a Fixed Priced IPO worth ₹22,96,000 Equity Shares of Rs 10 aggregating up to Rs 19.52 Cr. The issue price is ₹85 per share (fixed price). The IPO opens on Sep 29, 2017 and closes on Oct 4, 2017. It will be listed on NSE SME Platform. Link Intime India Private Ltd is the registrar.
The issue price of Beta Drugs Limited IPO is ₹85 per share (fixed price).
The lot size of Beta Drugs Limited IPO is 1600 shares.
The minimum investment for Beta Drugs Limited IPO is approximately ₹1,36,000 based on the issue price .
Beta Drugs Limited IPO opens on Sep 29, 2017 and closes on Oct 4, 2017.
The allotment date of Beta Drugs Limited IPO is Oct 9, 2017.
Beta Drugs Limited IPO is expected to be listed on Oct 12, 2017, on NSE SME Platform.
No recorded Grey Market Premium (GMP) quote is currently available for Beta Drugs Limited IPO. GMP is unofficial and does not forecast or guarantee the actual listing price.
Beta Drugs Limited IPO valuation snapshot: P/E 14.19, EPS Rs 5.99, P/B N/A, RoNW 70.18%, and market cap N/A.
To apply for Beta Drugs Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Beta Drugs Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Beta Drugs Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Beta Drugs Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Beta Drugs Limited IPO allotment status on IPO Ji for quick and easy access.